AUS
NZ
UK
CA
USA
IND
Highlights
- Uniphar PLC (LSE:UPR) announced to pay an interim dividend of 0.64 euro cents per share in October.
- In H1 FY23, the company registered approximately 4.9% year-on-year growth in interim dividend payment.
- The company witnessed a YoY growth of around 11.7% in the operating profit to €28.01 million.
FTSE AIM 100 index listed Uniphar PLC (LSE:UPR) is a diversified healthcare services business servicing the requirements of over 200 multinational pharmaceuticals and medical technology. Recently, the company has made a significant strategic investment in a new distribution facility and acquired McCauley to level up its market leadership position in Supply Chain & Retail division. Also, Uniphar has completed major acquisitions like BModesto and Orspec in its Product Access division to widen its reach in continental Europe and the APAC region.
For the first half of FY23, the company registered approximately 4.9% year-on-year growth in interim dividend payment.
Despite continued macro-economic uncertainty and inflationary pressure, Uniphar secured 25.0% increase in its top-line business in the reporting period. The company achieved a YoY growth of around 11.7% in the operating profit to €28.01 million. Notably, Uniphar doubled its 2018 pro forma EBITDA in H1 FY23.
The firm has announced to pay an interim dividend of 0.64 euro cents per share in October, with an ex-dividend date of 28 September 2023.
Going forth, the company is planning to make an investment of about €60 million of strategic capital expense in an IT and ERP investment programme. The objective is to strengthen the company’s Supply Chain & Retail division and enhance its global Pharma platforms. Uniphar is targeting €200 million Group EBITDA over the medium-term.
Top 10 Shareholders
Approximately 43.01% of the total shareholdings of the firm is held by its top ten shareholders. While Allianz Global Investors GmbH is the biggest shareholder with 10.05% stake, Polar Capital LLP owns over 7.37% shareholding.
Stock Price Performance
UPR’s stock price has fallen 14.66% in the last one month. It has dropped by 26.66% over the last six months. The stock’s 52-week low and high price are GBX 186.00 and GBX 334.00, respectively.
Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference data for all price data, currency, technical indicators, support, and resistance levels is 18 October 2023. The reference data in this report has been partly sourced from EODHD/Others.
